Plain-English translation of NCT05936606 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After you receive a stent in your heart arteries, you need to take blood-thinning medications to prevent clots. This trial is testing whether doctors can give you a better, more personalized approach by checking how your blood responds to the standard medication (clopidogrel) and then adjusting your treatment based on those results. Some patients may do well staying on the standard medication alone, while others with stronger clotting may benefit from taking two medications instead.
Even after taking blood-thinning medications as prescribed, some patients' blood still clots too easily, which increases their risk of heart attack or stroke. This trial wants to see if testing your individual response to medication and adjusting your treatment accordingly can prevent these serious events better than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups for 24 months. One group will continue taking clopidogrel alone. The other group will have a blood test to measure how your blood responds to clopidogrel; depending on those results and your individual risk factors, you may continue clopidogrel alone or switch to a combination of two medications. Your doctor will monitor you throughout the study to check for heart problems or bleeding and adjust your treatment if needed.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
South Korea